Healio
Healio
An double image of an armpit with hair and HS marks against a grey background with the one on the left side darker in contrast than the right side one

Take Homes in Hidradenitis Suppurativa
ByHaley Naik, MD
ByMarley V. Ghizzone

Read more

April 20, 2022
15 min watch
Save

VIDEO: Hidradenitis suppurativa patient experience, management, care ‘key themes’ at meeting

ByHaley Naik, MD
ByMarley V. Ghizzone
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this video, Haley Naik, MD, discusses “three key themes” from the hidradenitis suppurativa symposiums at the American Academy of Dermatology Annual Meeting.

Naik, associate professor and director of the hidradenitis suppurativa program at University of California, San Francisco and board member of the U.S. Hidradenitis Suppurativa Foundation, specifically highlighted the experience of patients living with HS, medical and surgical management of HS and collaborative care.

References:

  • Naik H, et al. S037 Symposium. Hidradenitis suppurativa/acne inversa (HS/AI): Current medical and surgical management. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
  • Andrews R. S037 Symposium. Living with HS. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
  • Garg A. S037 Symposium. Epidemiology and comorbidities of HS. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
  • Goldberg S. S037 Symposium. Surgical management of HS. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
  • Kirby JS. S037 Symposium. Medical management of HS with biologic therapies. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
  • Lowes MA. S037 Symposium. Pathophysiology of hidradenitis suppurativa. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
  • Naik H. S037 Symposium. Medical management of HS with non-biologic therapies. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
Sources/Disclosures

Collapse
Source: Healio Interview
Disclosures: Naik reports receiving grant support from AbbVie; receiving consulting fees from 23andMe, AbbVie, Aristea Therapeutics Inc., DAVA Oncology, Medscape and Nimbus Therapeutics; receiving advisory board fees from Boehringer Ingelheim; and receiving investigator fees from Pfizer.

Read more about

hidradenitis suppurativa
university of california san francisco
infliximab
bimekizumab
adalimumab
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

 

Related Content